MoneyWorks4Me

Blue Jet Healthcare informs about change in directorate

19 Nov 2024 Evaluate
Pursuant to Regulation 30 read with schedule III of SEBI (LODR) Regulation 2015, Blue Jet Healthcare has informed that the Board of Directors of the Company at the meeting held today, based on the recommendation of the NRC and subject to approval of the shareholders of the Company, have unanimously approved reappointment of the following Independent Directors for a period of 5 years: Girish P Vanvari, Divya Sameer Momaya, and Preeti G Mehta; appointment of Independent Director Priyanka Yadav; and appointment of Popat Kedar as an Executive Director.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..